COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Tecarfarin Anti-Coagulation Trial (TACT) (TACT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02522221
Recruitment Status : Unknown
Verified January 2018 by Espero Biopharma.
Recruitment status was:  Not yet recruiting
First Posted : August 13, 2015
Last Update Posted : January 25, 2018
Information provided by (Responsible Party):
Espero Biopharma

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : March 30, 2019
Estimated Study Completion Date : July 1, 2019